Petros Pharmaceuticals, Inc.
Cash Flow History
| Period | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| Mar 2020 | $-2.4M | $-2.4M | $4.4K | — |
| Mar 2021 | $-446.6K | $-446.6K | — | $347.2K |
| Mar 2022 | $-5.3M | $-5.3M | — | $355.8K |
| Mar 2023 | $-748.4K | $-748.4K | — | $130.3K |
| Mar 2024 | $-1.1M | $-1.1M | — | — |
| Mar 2025 | $-1.7M | $-1.7M | — | $80.0K |
| Mar 2026 | $-784.3K | $-784.3K | — | $120.3K |